Using simulation modeling techniques, we projected outcomes for hypothetical cohorts of BRCA2 mutation carriers, with varying numbers of first-degree relatives with a history of pancreatic cancer, that underwent MRI-based pancreatic screening strategies. The gene discussed is BRCA2; the disease is familial pancreatic carcinoma.